Mohs for DFSP and other uncommon skin tumors

Mohs surgery is best known for treating basal and squamous cell carcinoma, but its complete-margin approach also suits a group of uncommon skin tumors that share one difficult habit: they extend far beyond what the eye can see. For these rarer cancers, the same feature that makes Mohs valuable for common tumors, reading essentially the entire margin under the microscope before the wound is closed, becomes even more important, because a blind margin is especially likely to leave hidden roots behind.

Dermatofibrosarcoma protuberans is the classic example. DFSP is a rare, usually slow-growing soft-tissue cancer of the skin that seldom spreads to distant sites but is notoriously aggressive locally, sending finger-like projections well past its visible edge. The National Cancer Institute describes DFSP as a tumor that tends to recur after surgery if any of those extensions are missed. That is precisely the problem complete margin control is built to solve, and Mohs, or a closely related staged excision that checks the full peripheral margin, is associated with substantially lower recurrence than a standard wide excision that samples only part of the edge.

Several other rare tumors benefit from the same margin control. Microcystic adnexal carcinoma, sebaceous carcinoma, extramammary Paget disease, and atypical fibroxanthoma are among the uncommon cutaneous tumors for which Mohs or complete-margin techniques are used in appropriate cases, as summarized by dermatology references such as DermNet. What links them is a tendency toward subclinical spread, the same invisible extension that makes certain basal and squamous cell subtypes so treacherous. When a tumor is known to reach beyond its apparent border, examining the whole margin rather than a fraction is the logical response.

Complete margins matter even more for these tumors than for common ones. A standard excision commits to a fixed margin of normal-looking skin and then samples only a portion of the true edge in the pathology lab days later. For a tumor whose roots wander unpredictably, that sampling can easily miss a stealthy extension, and the cancer returns. By tracking the tumor wherever it actually reaches and confirming clearance in the same session, Mohs directly addresses the exact reason these rare cancers recur, while still sparing as much healthy tissue as the tumor allows.

These are specialist cases, and the right surgeon matters. Uncommon tumors are harder to interpret under the microscope than a routine basal cell carcinoma, and some require special stains or coordination with a pathologist, and occasionally confirmation on permanent sections after surgery. That makes an experienced, fellowship-trained Mohs surgeon especially important, sometimes working alongside a broader team when the tumor is large or deep. It is entirely reasonable to ask a surgeon how often they treat the specific tumor you have been diagnosed with.

Cure is strong, but follow-up remains essential. For DFSP and similar tumors, complete-margin surgery offers the most reliable local clearance available, and reported recurrence after Mohs is low, though these cancers still warrant ongoing surveillance because they can, rarely, return years later. As with any skin cancer, clearing the tumor thoroughly the first time is the best protection, which is also why Mohs is favored for cancers that have already come back once.

The practical message for a patient handed an unfamiliar diagnosis is not to panic at the rare name, but to ask the right question: does this tumor spread invisibly under the skin, and if so, would complete-margin surgery clear it more reliably than a standard excision? For DFSP and a handful of other uncommon cutaneous tumors, the answer is often yes, and seeking out a surgeon experienced in the technique is the step most associated with getting both the cure and the tissue-sparing benefit that make Mohs worth the day.

Related reading: Aggressive skin cancer subtypes and why Mohs matters and Finding an experienced Mohs surgeon